The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
Diabetes and cancer
Open accessAbstract
Diabetes and cancer are two heterogeneous, multifactorial, severe, and chronic diseases. Because of their frequency, reciprocal influences - even minor influences - may have a major impact. Epidemiological studies clearly indicate that the risk of several types of cancer (including pancreas, liver, breast, colorectal, urinary tract, and female reproductive organs) is increased in diabetic patients. Mortality is also moderately increased. Several confounding factors, having general or site-specific relevance, make it difficult to accurately assess cancer risk in diabetic patients. These factors include diabetes duration, varying levels of metabolic control, different drugs used for therapy, and the possible presence of chronic complications. Hyperinsulinemia most likely favors cancer in diabetic patients as insulin is a growth factor with pre-eminent metabolic but also mitogenic effects, and its action in malignant cells is favored by mechanisms acting at both the receptor and post-receptor level. Obesity, hyperglycemia, and increased oxidative stress may also contribute to increased cancer risk in diabetes. While anti-diabetic drugs have a minor influence on cancer risk (except perhaps the biguanide metformin that apparently reduces the risk), drugs used to treat cancer may either cause diabetes or worsen a pre-existing diabetes. In addition to the well-known diabetogenic effect of glucocorticoids and anti-androgens, an increasing number of targeted anti-cancer molecules may interfere with glucose metabolism acting at different levels on the signaling substrates shared by IGF-I and insulin receptors. In conclusion, diabetes and cancer have a complex relationship that requires more clinical attention and better-designed studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Diabetes is associated with reduced risk of prostate cancer.”
From Diabetes and Cancer (2010) · cites this paper as [6]
In the citing paper
“Diabetes (primarily type 2) is associated with increased risk for some cancers (liver, pancreas, endometrium, colon and rectum, breast, bladder).”
From Diabetes and Cancer (2010) · cites this paper as [6]
In the citing paper
“Epidemiologic evidence suggests that people with diabetes are at significantly higher risk for many forms of cancer.”
From Diabetes and Cancer (2010) · cites this paper as [6]
In the citing paper
“For some other cancer sites there appears to be no association or the evidence is inconclusive.”
From Diabetes and Cancer (2010) · cites this paper as [6]
In the citing paper
“Other cancers (e.g., lung) do not appear to be associated with an increased risk in diabetes, and the evidence for others (e.g., kidney, non-Hodgkin lymphoma) is inconclusive.”
From Diabetes and Cancer (2010) · cites this paper as [6]
In the citing paper
“The relative risks imparted by diabetes are greatest (about twofold or higher) for cancers of the liver, pancreas, and endometrium, and lesser (about 1.2–1.5 fold) for cancers of the colon and rectum, breast, and bladder.”
From Diabetes and Cancer (2010) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
Hoskins, R. G. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-4-473 · Cited by 3,780
THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(1911) · JAMA · doi:10.1001/jama.1911.04260070032017 · Cited by 3,355
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
The American Journal of Gastroenterology
(2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.80003397.x · Cited by 2,202
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
Archives of Biochemistry and Biophysics
Carter, H. E., Bhattacharyya, P., Weidman, K. R., & Fraenkel, G. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1981.tb06727.x · Cited by 1,895
Research works printed but not linked: 1
- Lindblad P Adami HO 2002 Kidney cancer. In Textbook of Cancer Epidemiology, pp 467–485 Eds HunterDAdamiHOTrichopoulosD. New York: Oxford University Press.
Cited by
Sorted by citations
Items 401–500 of 1,000
Haake, S. M., Brooks, S. A., Welsh, E. A., Fulp, W. J., Chen, D., Dhillon, J., Haura, E. B., Sexton, W. J., Spiess, P. E., Pow‐Sang, J. M., et al. (2015) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2015.09.015 · Cited by 31
Park, D.-B. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.6.518 · Cited by 31
Mekuria, A. N., Ayele, Y., Tola, A., & Mishore, K. M. (2019) · Journal of Diabetes Research · doi:10.1155/2019/7676909 · Cited by 29
“predominantly T2DM, and certain types of cancer [5].”
BackgroundCancer and diabetes co-occurrence: A national study with 44 million person-years of follow-up
Gurney, J., Stanley, J., Teng, A. M., Krebs, J. D., Koea, J., Lao, C., Lawrenson, R. A., Meredith, I., Sika‐Paotonu, D., & Sarfati, D. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276913 · Cited by 30
“Relatedly, while it is thought that drugs used to treat cancer may either cause diabetes or worsen pre-existing diabetes [62], the current study was designed to detect new cases of cancer amongst those already with diabetes, meaning that we were unable to examine reverse causation (i.”
BackgroundSignaling steps in the induction of genomic damage by insulin in colon and kidney cells
Othman, E. M., Hintzsche, H., & Stopper, H. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.12.010 · Cited by 31
Kao, C., Sun, L. M., Chen, P., Lin, M.-C., Liang, J., Muo, C.-H., Chang, S.-N., & Sung, F. (2012) · Annals of Oncology · doi:10.1093/annonc/mds472 · Cited by 30
The Role of Diabetes in Acromegaly Associated Neoplasia
Cheng, S., Gomez, K., Serri, O., Chik, C. L., & Ezzat, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127276 · Cited by 31
Homayounfar, R., Jeddi‐Tehrani, M., Cheraghpour, M., Ghorbani, A., & Zand, H. (2014) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2014.06.029 · Cited by 32
“It seems that such a contradiction may explain high incidence of cancer in obese and diabetic patients (van Kruijsdijk et al., 2009; Vigneri et al., 2009), which is more serious among the diabetic patients who receive stimulator of insulin secretion than those receiving insulin sensitizer drugs.”
BackgroundSkin autofluorescence predicts cancer in subjects with type 2 diabetes
Foussard, N., Larroumet, A., Rigo, M., Mohammedi, K., Baillet‐Blanco, L., Poupon, P., Monlun, M., Lecocq, M., Devouge, A., Ducos, C., et al. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001312 · Cited by 29
Diabetes and cancer: A 2013 synopsis
Buysschaert, M., & Sadikot, S. S. (2013) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2013.08.001 · Cited by 29
Harman, E., Erten, Ç., Küçükzeybek, Y., Dırıcan, A., Er, H., & Oktay, T. M. (2012) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2012.13.10.5143 · Cited by 29
Bannasch, P., Ribback, S., Su, Q., & Mayer, D. (2017) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(17)60071-7 · Cited by 29
Diabetes in the practice of otolaryngology
Atsmoni, S. C., Brener, A., & Roth, Y. (2019) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2019.01.006 · Cited by 30
Mascolo, E., Amoroso, N., Saggio, I., Merigliano, C., & Vernı̀, F. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28990 · Cited by 29
Sehdev, A., & O’Neil, B. H. (2015) · Current Treatment Options in Oncology · doi:10.1007/s11864-015-0359-z · Cited by 28
Nakamura, K., Wada, K., Tamai, Y., Tsuji, M., Kawachi, T., Hori, A., Takeyama, N., Tanabashi, S., Matsushita, S., Tokimitsu, N., et al. (2013) · Cancer Science · doi:10.1111/cas.12235 · Cited by 29
Genomic instability in patients with type 2 diabetes mellitus on hemodialysis
Palazzo, R. P., Bagatini, P. B., Schefer, P. B., de Andrade, F. M., & Maluf, S. W. (2011) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.5581/1516-8484.20120011 · Cited by 29
Mughal, A., Kumar, D., & Vikram, A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.10.057 · Cited by 29
Diabetes mellitus, metformin and head and neck cancer
Figueiredo, R. A. D. O., Weiderpass, E., Tajara, E. H., Ström, P., Carvalho, A. L., de Carvalho, M. B., Kanda, J. L., Moysés, R. A., & Wünsch‐Filho, V. (2016) · Oral Oncology · doi:10.1016/j.oraloncology.2016.08.006 · Cited by 30
The Impact of Obesity and Metabolic Syndrome on Chronic Hepatitis C
Goossens, N., & Negro, F. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.09.007 · Cited by 28
“A series of recent studies andmeta-analyses confirmed that the risk of several types of malignancies, including HCC, is increased in the setting of type 2 diabetes.(51) In population-based data of 19,349 diabetic patients and 77,396 controls in Taiwan, Lai and colleagues(52) found that diabetes was associated with a d…”
Othman, E. M., Kreissl, M. C., Kaiser, F. R., Arias-Loza, P.-A., & Stopper, H. (2013) · Endocrinology · doi:10.1210/en.2012-1768 · Cited by 28
“Furthermore, there is a relationship between hyperinsulinemia and the development of different types of cancer (3-10).”
BackgroundRibback, S., Calvisi, D. F., Cigliano, A., Sailer, V. W., Peters, M., Rausch, J., Heidecke, C.-D., Birth, M., & Dombrowski, F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.01.013 · Cited by 28
Müllner, E., Brath, H., Nersesyan, A. K., Nitz, M., Petschnig, A., Wallner, M., Knasmüller, S., & Wagner, K. (2013) · Mutagenesis · doi:10.1093/mutage/get056 · Cited by 28
Diabetology and oncology meet in a network model: union is strength
Gallo, M., Gentile, L., Arvat, E., Bertetto, O., & Clemente, G. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0839-z · Cited by 28
“Obesity, insulin resistance, diabetes, and cancer are heterogeneous, multifactorial, and chronic diseases influencing each other [4].”
BackgroundKřížková, K., Chrudinová, M., Povalová, A., Selicharová, I., Collinsová, M., Vaněk, V., Brzozowski, A. M., Jiráček, J., & Žáková, L. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00140 · Cited by 31
Li, S., Yang, F., Kumagai, A., Kawakita, E., Kitada, M., Kanasaki, K., & Koya, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030805 · Cited by 28
Short‐term risk of cancer among women with previous gestational diabetes: a population‐based study
Bejaimal, S. A. D., Wu, C. F., LOWE, J. M., Feig, D. S., Shah, B. R., & Lipscombe, L. L. (2015) · Diabetic Medicine · doi:10.1111/dme.12796 · Cited by 28
Sung, H., Hung, C., Tung, Y., Lin, C., Tsai, T., & Huang, K. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3784 · Cited by 27
Attenuation of NK cells facilitates mammary tumor growth in streptozotocin-induced diabetes in mice
Gajović, N., Jurišević, M., Pantic, J. M., Radosavljevic, G. D., Arsenijević, N., Lukić, M. L., & Jovanović, I. (2018) · Endocrine Related Cancer · doi:10.1530/erc-17-0529 · Cited by 27
Association between diabetes, obesity, aging, and cancer: review of recent literature
Qiang, J. K., Lipscombe, L. L., & Lega, I. C. (2020) · Translational Cancer Research · doi:10.21037/tcr.2020.03.14 · Cited by 28
Saengboonmee, C., Phoomak, C., Supabphol, S., Covington, K. R., Hampton, O. A., Wongkham, C., Gibbs, R. A., Umezawa, K., Seubwai, W., Gingras, M., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118548 · Cited by 27
“, hyperinsulinemia, insulin-like growth factor, ketone bodies, and proinflammatory cytokines [1] may also act as tumor promoting factors.”
BackgroundIrizarry, L., Li, Q. E., Duncan, I. G., Thurston, A. L., Fitzner, K. A., Edwards, B. J.-A., McKoy-Bent, J. M., Tulas, K. M., & McKoy, J. M. (2012) · Population Health Management · doi:10.1089/pop.2012.0028 · Cited by 27
Sharma, A., Ng, H., Kumar, A., Teli, K., Randhawa, J., Record, J., & Maroules, M. (2013) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2013.10.002 · Cited by 29
Diabetes, insulin use, and non-Hodgkin lymphoma mortality in Taiwan
Tseng, C. (2012) · Metabolism · doi:10.1016/j.metabol.2011.11.015 · Cited by 27
Obesity and cancer: at the crossroads of cellular metabolism and proliferation
O’Rourke, R. W. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.08.012 · Cited by 28
Preventing breast cancer in women with schizophrenia
Seeman, M. V. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01626.x · Cited by 27
Ahn, J. H., Jung, S. I., Yim, S. U., Kim, S. W., Hwang, E. C., & Kwon, D. D. (2016) · Journal of Korean Medical Science · doi:10.3346/jkms.2016.31.9.1464 · Cited by 27
de Jong, R. G. P. J., Peeters, P. J. H. L., Burden, A. M., Bruin, M. L. D., Haak, H. R., Masclee, A., de Vries, F., & Janssen-Heijnen, M. L. G. (2018) · Cancer Epidemiology · doi:10.1016/j.canep.2018.04.008 · Cited by 28
Sandini, M., Strobel, O., Hank, T. P., Lewosinska, M., Nießen, A., Hackert, T., Büchler, M. W., & Schimmack, S. J. (2019) · Surgery · doi:10.1016/j.surg.2019.11.007 · Cited by 27
Mroueh, F. M., Noureldein, M. H., Zeidan, Y. H., Boutary, S. S., Irani, S. A. M., Eid, S., Haddad, M. E., Barakat, R., Harb, F., Costantine, J., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900396rr · Cited by 26
Diabetes and Prostate Cancer Outcomes in Obese and Nonobese Men After Radical Prostatectomy
Kelkar, S., Oyekunle, T. O., Eisenberg, A., Howard, L. E., Aronson, W. J., Kane, C. J., Amling, C. L., Cooperberg, M. R., Klaassen, Z. W. A., Terris, M. K., et al. (2021) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkab023 · Cited by 28
Diabetes mellitus and the risk of bladder cancer: an Italian case–control study
Turati, F., Polesel, J., Maso, M. D., Montella, M., Libra, M., Grimaldi, M., Tavani, A., Serraino, D., Vecchia, C. L., & Bosetti, C. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.178 · Cited by 26
K-ras gene mutation as a predictor of cancer cell responsiveness to metformin
Ma, Y., Guo, F., Wang, W., Shi, H., Li, D., & Wang, Y. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1596 · Cited by 26
Diabetes and the risk for colorectal cancer
Erbach, M., Mehnert, H., & Schnell, O. (2012) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2011.11.003 · Cited by 26
“It may be assumed that the large majority of cancer in diabetic patients is observed in type 2 diabetes (Vigneri et al., 2009).”
BackgroundInfluentialNoh, Y., Jeon, S., & Shin, S. (2018) · International Journal of Cancer · doi:10.1002/ijc.31870 · Cited by 28
Is Vitamin D Deficiency Related to Increased Cancer Risk in Patients with Type 2 Diabetes Mellitus?
Gabryanczyk, A., Klimczak, S., Szymczak-Pajor, I., & Śliwińska, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126444 · Cited by 25
Hyperglycemia-driven signaling bridges between diabetes and cancer
Ghareghomi, S., Arghavani, P., Mahdavi, M., Khatibi, A., García‐Jiménez, C., & Moosavi‐Movahedi, A. A. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116450 · Cited by 29
Ye, C., Li, X., Wang, Y., Zhang, Y., Cai, M., Zhu, B., Mu, P., Xia, X., Zhao, Y. D., Weng, J., et al. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.87 · Cited by 25
Balzano, G., Dugnani, E., Pasquale, V., Capretti, G. L., Radaelli, M. G., Garito, T., Stratta, G., Nini, A., Fenza, R. D., Castoldi, R., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0614-y · Cited by 25
“In fact, while long-duration diabetes is considered a risk factor for the development of pancreatic ductal cancer [20–24], recent-onset diabetes in these Table 3 Variables related to glucose tolerance in patients with pancreatic disease, according to the duration of diabetes”
BackgroundInterpreting Adverse Signals in Diabetes Drug Development Programs
Bailey, C. J. (2013) · Diabetes Care · doi:10.2337/dc13-0182 · Cited by 25
Okada, S., Morimoto, T., Ogawa, H., Sakuma, M., Matsumoto, C., Soejima, H., Nakayama, M., Doi, N., Jinnouchi, H., Waki, M., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0368 · Cited by 25
“has been shown to confer a higher risk of cancer in Japan (8) and in other countries (30).”
BackgroundKim, S. K., Jang, J., Kim, D., Rhyu, Y. A., Lee, S. E., Ko, S., Han, K., & Song, K. (2018) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2017.402 · Cited by 25
“Increased endogenous insulin levels resulting from insulin resistance, hyperglycemia, chronic inflammation, and increased oxidative stress have been suggested to be the main mechanism responsible for increased cancer risk in patients with diabetes [10,12].”
BackgroundDrosophila as a toolkit to tackle cancer and its metabolism
Jiang, H., Kimura, T., Hai, H., Yamamura, R., & Sonoshita, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.982751 · Cited by 25
Comorbidities associated with bladder dysfunction
Tannenbaum, C., Gray, M., Hoffstetter, S., & Cardozo, L. (2013) · International Journal of Clinical Practice · doi:10.1111/ijcp.12085 · Cited by 25
Diabetes mellitus and risk of brain tumors: A meta-analysis
TONG, J. J., TAO, H., HUI, O. T., & Chen, J. (2012) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2012.698 · Cited by 25
Bedinger, D., Goldfine, I. D., Corbin, J., Roell, M. K., & Adams, S. H. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.221309 · Cited by 25
Yokomichi, H., Nagai, A., Hirata, M., Kiyohara, Y., Muto, K., Ninomiya, T., Matsuda, K., Kamatani, Y., Tamakoshi, A., Kubo, M., et al. (2017) · Journal of Epidemiology · doi:10.1016/j.je.2016.12.012 · Cited by 26
Lodovici, M., Bigagli, E., Tarantini, F., Serio, C. D., & Raimondi, L. (2015) · Experimental Biology and Medicine · doi:10.1177/1535370215570826 · Cited by 24
Incidences of cancers in diabetic and non-diabetic hospitalized adult patients in Taiwan.
Chiou, W., Huang, B., Chou, W.-Y., Weng, H., & Lin, J. (2011) · PubMed · Cited by 24
Zuniga, K. B., Graff, R. E., Feiger, D. B., Meng, M. V., Porten, S. P., & Kenfield, S. A. (2019) · Bladder Cancer · doi:10.3233/blc-190249 · Cited by 24
“More generally, hyperglycemia may dysregulate energy balance, which affects intracellular metabolism and impairs immune function, leading to increased risk of multiple different cancer types [124].”
Nadimi-Shahraki, M. H., Mohammadi, S., Zamani, H., Gandomi, M., & Gandomi, A. H. (2021) · Electronics · doi:10.3390/electronics10243167 · Cited by 24
Glucose Metabolism Disorders and the Risk of Cancer
Piątkiewicz, P., & Czech, A. (2011) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-011-0119-0 · Cited by 26
Peng, X., Meng, X., Cheng, W., Xing, Z., Huang, J., Fang, Z., Hu, X., Liu, Q., Zhu, Z., & Zhou, S. (2018) · Cancer Management and Research · doi:10.2147/cmar.s181178 · Cited by 24
Muhammad, I. F., Borné, Y., Bao, X., Melander, O., Orho‐Melander, M., Nilsson, P. M., Nilsson, J. Å., & Engström, G. (2019) · Diabetes Care · doi:10.2337/dc18-2556 · Cited by 24
Effect of hyperglycemia on hepatocellular carcinoma development in diabetes
Niwa, Y., Ishikawa, K., Ishigami, M., Honda, T., Achiwa, K., Izumoto, T., Maekawa, R., Hosokawa, K., Iida, A., Seino, Y., et al. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.05.066 · Cited by 24
Othman, E. M., Oli, R. G., Arias-Loza, P.-A., Kreissl, M. C., & Stopper, H. (2016) · Endocrinology · doi:10.1210/en.2015-1572 · Cited by 23
Diabetes, Insulin Use, and Gastric Cancer
Tseng, C. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31827245eb · Cited by 23
Yang, W., Yang, Y., Yang, G., Chow, W., Li, H.-L., Gao, Y.-T., Ji, B., Rothman, N., Zheng, W., Shu, X., et al. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004875 · Cited by 23
Risk of asthma and autoimmune diseases and related conditions in patients hospitalized for obesity
Hemminki, K., Li, X., Sundquist, J., & Sundquist, K. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.547515 · Cited by 24
Ferro, A., Goyal, S., Kim, S., Wu, H., Taunk, N. K., Schiff, D. S., Pirlamarla, A., & Haffty, B. G. (2013) · International Journal of Breast Cancer · doi:10.1155/2013/659723 · Cited by 23
Relationship between metformin and frailty syndrome in elderly people with type 2 diabetes.
Sumantri, S., Setiati, S., Purnamasari, D., & Dewiasty, E. (2014) · Acta medica Indonesiana · Cited by 22
Chen, Y., Liu, R., Chu, Z., Bu, L., Zeng, H., Zhang, X., Wu, Q., Zhu, G., Chen, Y., Liu, Y., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26803 · Cited by 23
Parada, H., Cleveland, R. J., North, K. E., Stevens, J., Teitelbaum, S. L., Neugut, A. I., Santella, R. M., Martı́nez, M. E., & Gammon, M. D. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22940 · Cited by 24
“Diabetes is a known risk factor for heart disease, stroke, nephropathy, and neuropathy and cancers of the liver, pancreas, endometrium, and colon/rectum.(2) Accumulating epidemiologic evidence suggests that diabetes may also increase the risk of developing breast cancer (BC), the most frequently diagnosed cancer among…”
BackgroundInsulin resistance and adrenal incidentalomas: A bidirectional relationship
Sydney, G. I., Ioakim, K. J., & Paschou, S. Α. (2018) · Maturitas · doi:10.1016/j.maturitas.2018.12.002 · Cited by 23
Thymic emigration patterns in patients with type 2 diabetes treated with metformin
Dworacki, G., Urazayev, O., Bekmukhambetov, Y., Iskakova, S., Frycz, B. A., Jagodziński, P. P., & Dworacka, M. (2015) · Immunology · doi:10.1111/imm.12522 · Cited by 23
Kim, K., Kim, B., & Han, K. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0780 · Cited by 22
The Role of Insulin Resistance in Cancer
Subedi, B. K., Bhimineni, C., Modi, S., Jahanshahi, A., Quiza, K., & Bitetto, D. (2025) · Current Oncology · doi:10.3390/curroncol32090477 · Cited by 26
“• Altered IGF-Axis Signaling: Hyperinsulinemia suppresses the hepatic production of IGF-binding proteins (IGFBP-1 and IGFBP-2), which may increase the bioavailability of IGF-1 [20,21].”
Budny, V., Ruminot, I., Wybitul, M., Treyer, V., Barros, L. F., & Tackenberg, C. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03550-w · Cited by 25
Wild, S. H. (2011) · Diabetologia · doi:10.1007/s00125-011-2169-6 · Cited by 22
Gastric Xanthoma Associated with Gastric Cancer Development: An Updated Review
Moumin, F. A., Mohamed, A. A., Osman, A. A., & Cai, J. (2020) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2020/3578927 · Cited by 22
Epidemic Trends of Obesity with Impact on Metabolism and Digestive Diseases
Feneberg, A. C., & Malfertheiner, P. (2012) · Digestive Diseases · doi:10.1159/000336660 · Cited by 22
The Relationship between Metformin and Cancer in Patients with Type 2 Diabetes
Chung, H. H., Moon, J. S., Yoon, J. S., Lee, H. W., & Won, K. C. (2013) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2013.37.2.125 · Cited by 22
Metabolic syndrome-breast cancer link varies by intrinsic molecular subtype
Capasso, I., Esposito, E., Laurentiis, M. D., Maurea, N., Cavalcanti, E., Botti, G., Petrillo, A., Montella, M., D’Aiuto, M., Coppola, C., et al. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-105 · Cited by 22
DNA-aptamers raised against AGEs as a blocker of various aging-related disorders
Yamagishi, S., Taguchi, K., & Fukami, K. (2016) · Glycoconjugate Journal · doi:10.1007/s10719-016-9682-2 · Cited by 22
Abo–Elmatty, D. M., Ahmed, E., Tawfik, M. K., & Helmy, S. A. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.01.002 · Cited by 22
Prevention of pancreatic acinar cell carcinoma by Roux-en-Y Gastric Bypass Surgery
He, R., Yin, Y., Yin, W., Li, Y., Zhao, J., & Zhang, W. (2018) · Nature Communications · doi:10.1038/s41467-018-06571-w · Cited by 22
Berstein, L. M., Boyarkina, M. P., & Teslenko, S. Y. (2011) · Medical Oncology · doi:10.1007/s12032-011-9840-0 · Cited by 21
Diabetes and skin cancers: Risk factors, molecular mechanisms and impact on prognosis
Dobrică, E.-C., Banciu, L. M., Kipkorir, V., Tabari, M. A. K., Cox, M. J., Kutikuppala, L. V. S., & Găman, M. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i31.11214 · Cited by 23
Chan, R. N. C., Chan, R. N. F., Chou, O. H. I., Tse, G., & Lee, S. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.01.021 · Cited by 21
Santi, M. D., Annibalini, G., Marano, G., Biganzoli, G., Venturelli, E., Pellegrini, M., Lucertini, F., Brandi, G., Biganzoli, E. M., Barbieri, E., et al. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-04755-6 · Cited by 21
Hsu, C., Sulake, R. S., Huang, P., Shih, H., Sie, H., Lai, Y., Chen, C., & Weng, C. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12828 · Cited by 21
Nie, S., Chen, H., Zhuang, M., & Lü, M. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.16.6863 · Cited by 21
The Prognostic Impact of Type 2 Diabetes Mellitus on Early Cervical Cancer in Asia
Kuo, H., Lin, Z., Kuo, R. N.-C., Shau, W., Lai, C.-L., Yang, Y., Shao, Y., Hsu, C., Cheng, W.-F., Cheng, A., et al. (2015) · The Oncologist · doi:10.1634/theoncologist.2015-0111 · Cited by 21
Palivec, V., Viola, C., Kozak, M., Ganderton, T., Křížková, K., Turkenburg, J. P., Halušková, P., Žáková, L., Jiráček, J., Jungwirth, P., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.775924 · Cited by 21
Ji, Q. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.03.013 · Cited by 21
Risk of stomach cancer in Aotearoa/New Zealand: A Māori population based case-control study
Ellison‐Loschmann, L., Sporle, A. A., Corbin, M., Cheng, S., Harawira, P., Gray, M. J., Whaanga, T., Guilford, P., Koea, J., & Pearce, N. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181581 · Cited by 21
GScluster: network-weighted gene-set clustering analysis
Yoon, S., Kim, J., Kim, S., Baik, B., Chi, S.-M., Kim, S., & Nam, D. (2019) · BMC Genomics · doi:10.1186/s12864-019-5738-6 · Cited by 20
Urbanová, M., Mráz, M., Ďurovcová, V., Trachta, P., Kloučková, J., Kaválková, P., Haluzíková, D., Lacinová, Z., Hansíková, H., Wenchich, L., et al. (2017) · Physiological Research · doi:10.33549/physiolres.933469 · Cited by 21
“Type 2 diabetes is a well-known risk factor for atherosclerosis and subsequent cardiovascular and cerebrovascular diseases as well as for specific types of cancer (Paneni et al. 2014, Laakso and Kuusisto 2014, Vigneri et al. 2009, Matloch et al. 2016).”
BackgroundPopulation‐based cohort studies of type 2 diabetes and stomach cancer risk in Chinese men and women
Xu, H., Tan, Y., Epplein, M., Li, H., Gao, J., Gao, Y., Zheng, W., Shu, X., & Xiang, Y. (2014) · Cancer Science · doi:10.1111/cas.12597 · Cited by 21
Links between obesity, diabetes and ethnic disparities in breast cancer among Hispanic populations
Lopez, R., Agullo, P. A., & Lakshmanaswamy, R. (2013) · Obesity Reviews · doi:10.1111/obr.12030 · Cited by 21
Metadata
- Authors
- Vigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R.
- Affiliations
- Section of General Pathology 1
- University of Catania (IT)
- Corresponding author
- Vigneri, Paolo
- Venue
- Endocrine Related Cancer
- Publisher
- Bioscientifica
- Published
- 2009-12-01
- Volume
- 16
- Issue
- 4
- Pages
- 1103-1123
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2163691729
- Cited by
- 1,009
- References
- 183
- Citations by year
- 2026: 20 · 2025: 43 · 2024: 54 · 2023: 49 · 2022: 49 · 2021: 46 · 2020: 50 · 2019: 57 · 2018: 60 · 2017: 75 · 2016: 59 · 2015: 68 · 2014: 85 · 2013: 97 · 2012: 80
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrine Related Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- diabetes mellitus, cancer risk, hyperinsulinemia, insulin-like growth factor I, insulin receptor, metformin, antidiabetic drugs, glucocorticoids, androgen receptor antagonists, obesity, hyperglycemia, oxidative stress, pancreatic cancer, liver cancer, breast cancer, colorectal cancer, cancer mortality, confounding factors
- MeSH terms
- Humans, Neoplasms, Risk Factors, Survival Rate, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
